Fish & Richardson P.C.
Fused pyrazine derivatives as A2A / A2B inhibitors
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases. 
Incyte Corporation
A A C C A A
A61P A61P C07D C07D A61P A61P
inventional inventional inventional inventional inventional inventional
Yong Wenqing Chao Wenyu Liangxing Xiaozhao
Li Yao Qi Zhu Wu Wang